Annual Current Liabilities
$3.13 M
+$649.80 K+26.16%
December 31, 2023
Summary
- As of February 12, 2025, ENTO annual total current liabilities is $3.13 million, with the most recent change of +$649.80 thousand (+26.16%) on December 31, 2023.
- During the last 3 years, ENTO annual current liabilities has fallen by -$12.41 million (-79.84%).
- ENTO annual current liabilities is now -79.84% below its all-time high of $15.55 million, reached on December 1, 2020.
Performance
ENTO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$15.69 M
+$305.60 K+1.99%
September 1, 2024
Summary
- As of February 12, 2025, ENTO quarterly total current liabilities is $15.69 million, with the most recent change of +$305.60 thousand (+1.99%) on September 1, 2024.
- Over the past year, ENTO quarterly current liabilities has increased by +$12.56 million (+400.76%).
- ENTO quarterly current liabilities is now -17.84% below its all-time high of $19.10 million, reached on September 1, 2021.
Performance
ENTO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ENTO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.2% | +400.8% |
| 3 y3 years | -79.8% | +497.8% |
| 5 y5 years | +4.6% | +169.6% |
ENTO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.5% | +26.2% | -9.2% | +532.0% |
| 5 y | 5-year | -79.8% | +26.2% | -17.8% | +532.0% |
| alltime | all time | -79.8% | +33.9% | -17.8% | +970.3% |
Entero Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.69 M(+2.0%) |
| Jun 2024 | - | $15.38 M(+149.2%) |
| Mar 2024 | - | $6.17 M(+97.0%) |
| Dec 2023 | $3.13 M(+26.2%) | $3.13 M(+26.2%) |
| Sep 2023 | - | $2.48 M(-23.9%) |
| Jun 2023 | - | $3.26 M(+24.2%) |
| Mar 2023 | - | $2.62 M(+5.7%) |
| Dec 2022 | $2.48 M(-79.8%) | - |
| Dec 2022 | - | $2.48 M(-62.9%) |
| Sep 2022 | - | $6.69 M(-61.3%) |
| Jun 2022 | - | $17.28 M(+21.6%) |
| Mar 2022 | - | $14.22 M(+15.6%) |
| Dec 2021 | $12.30 M(-20.9%) | $12.30 M(-35.6%) |
| Sep 2021 | - | $19.10 M(+195.9%) |
| Jun 2021 | - | $6.45 M(+80.6%) |
| Mar 2021 | - | $3.57 M(-77.0%) |
| Dec 2020 | $15.55 M | $15.55 M(+492.1%) |
| Sep 2020 | - | $2.63 M(-65.5%) |
| Jun 2020 | - | $7.62 M(+48.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $5.14 M(+20.0%) |
| Dec 2019 | $4.29 M(+43.1%) | $4.29 M(-26.4%) |
| Sep 2019 | - | $5.82 M(-6.5%) |
| Jun 2019 | - | $6.22 M(+8.1%) |
| Mar 2019 | - | $5.76 M(+92.2%) |
| Dec 2018 | $3.00 M(+20.8%) | $3.00 M(+104.3%) |
| Sep 2018 | - | $1.47 M(-43.9%) |
| Jun 2018 | - | $2.61 M(-7.4%) |
| Mar 2018 | - | $2.82 M(+13.7%) |
| Dec 2017 | $2.48 M(+5.9%) | $2.48 M(-9.2%) |
| Sep 2017 | - | $2.73 M(+6.7%) |
| Jun 2017 | - | $2.56 M(-3.5%) |
| Mar 2017 | - | $2.65 M(+13.3%) |
| Dec 2016 | $2.34 M(-73.4%) | $2.34 M(-84.9%) |
| Sep 2016 | - | $15.55 M(+8.7%) |
| Jun 2016 | - | $14.31 M(+39.9%) |
| Mar 2016 | - | $10.23 M(+16.0%) |
| Dec 2015 | $8.82 M(+262.6%) | $8.82 M |
| Dec 2014 | $2.43 M | - |
FAQ
- What is Entero Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Entero Therapeutics?
- What is Entero Therapeutics annual current liabilities year-on-year change?
- What is Entero Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Entero Therapeutics?
- What is Entero Therapeutics quarterly current liabilities year-on-year change?
What is Entero Therapeutics annual total current liabilities?
The current annual current liabilities of ENTO is $3.13 M
What is the all time high annual current liabilities for Entero Therapeutics?
Entero Therapeutics all-time high annual total current liabilities is $15.55 M
What is Entero Therapeutics annual current liabilities year-on-year change?
Over the past year, ENTO annual total current liabilities has changed by +$649.80 K (+26.16%)
What is Entero Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ENTO is $15.69 M
What is the all time high quarterly current liabilities for Entero Therapeutics?
Entero Therapeutics all-time high quarterly total current liabilities is $19.10 M
What is Entero Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ENTO quarterly total current liabilities has changed by +$12.56 M (+400.76%)